|
HY-133536-300ug
|
MedChemexpress LLC
|
PA Janelia Fluor� 549, SE [CAS 1811539-42-0]
|
|
|
|
|
HY-N1354-10mg
|
MedChemexpress LLC
|
Reynoutrin [CAS 549-32-6]
|
|
Neuroscience-Neurodegeneration
|
|
|
HY-N1354-25mg
|
MedChemexpress LLC
|
Reynoutrin [CAS 549-32-6]
|
|
Neuroscience-Neurodegeneration
|
|
|
HY-N1354-5mg
|
MedChemexpress LLC
|
Reynoutrin [CAS 549-32-6]
|
|
Neuroscience-Neurodegeneration
|
|
|
HY-N1354-50mg
|
MedChemexpress LLC
|
Reynoutrin [CAS 549-32-6]
|
|
Neuroscience-Neurodegeneration
|
|
|
HY-N1354-1mL
|
MedChemexpress LLC
|
Reynoutrin [CAS 549-32-6] (10mM in DMSO)
|
|
Neuroscience-Neurodegeneration
|
|
|
HY-D0989-1mg
|
MedChemexpress LLC
|
Rhod-2 AM [CAS 145037-81-6]
|
|
|
|
|
HY-B0527A-1g
|
MedChemexpress LLC
|
Amitriptyline (hydrochloride) [CAS 549-18-8]
|
|
Neuroscience-Neurodegeneration
|
|
|
HY-B0527A-5g
|
MedChemexpress LLC
|
Amitriptyline (hydrochloride) [CAS 549-18-8]
|
|
Neuroscience-Neurodegeneration
|
|
|
HY-B0527A-500mg
|
MedChemexpress LLC
|
Amitriptyline (hydrochloride) [CAS 549-18-8]
|
|
Neuroscience-Neurodegeneration
|
|
|
HY-B0527A-1mL
|
MedChemexpress LLC
|
Amitriptyline (hydrochloride) [CAS 549-18-8] (10mM in DMSO)
|
|
Neuroscience-Neurodegeneration
|
|
|
HY-10319-10mg
|
MedChemexpress LLC
|
BAY-549 [CAS 867017-68-3]
|
|
COVID-19-anti-virus
|
|
|
HY-10319-100mg
|
MedChemexpress LLC
|
BAY-549 [CAS 867017-68-3]
|
|
COVID-19-anti-virus
|
|
|
HY-10319-25mg
|
MedChemexpress LLC
|
BAY-549 [CAS 867017-68-3]
|
|
COVID-19-anti-virus
|
|
|
HY-10319-5mg
|
MedChemexpress LLC
|
BAY-549 [CAS 867017-68-3]
|
|
COVID-19-anti-virus
|
|
|
HY-10319-50mg
|
MedChemexpress LLC
|
BAY-549 [CAS 867017-68-3]
|
|
COVID-19-anti-virus
|
|
|
HY-10319-1mL
|
MedChemexpress LLC
|
BAY-549 [CAS 867017-68-3] (10mM in DMSO)
|
|
COVID-19-anti-virus
|
|
|
HY-N0753-1mg
|
MedChemexpress LLC
|
Eupalinolide B [CAS 877822-41-8]
|
|
Cancer-programmed cell death
|
|
|
HY-N0753-10mg
|
MedChemexpress LLC
|
Eupalinolide B [CAS 877822-41-8]
|
|
Cancer-programmed cell death
|
|
|
HY-N0753-5mg
|
MedChemexpress LLC
|
Eupalinolide B [CAS 877822-41-8]
|
|
Cancer-programmed cell death
|
|
|
HY-W050088-1g
|
MedChemexpress LLC
|
Isoxepac [CAS 55453-87-7]
|
|
COVID-19-immunoregulation
|
|
|
HY-W050088-500mg
|
MedChemexpress LLC
|
Isoxepac [CAS 55453-87-7]
|
|
COVID-19-immunoregulation
|
|
|
HY-131020-1mg
|
MedChemexpress LLC
|
Janelia Fluor� 525, SE
|
|
|
|
|
HY-131022-10mg
|
MedChemexpress LLC
|
Janelia Fluor� 549 (TFA) [CAS 2245946-45-4]
|
|
|
|
|
HY-131022-5mg
|
MedChemexpress LLC
|
Janelia Fluor� 549 (TFA) [CAS 2245946-45-4]
|
|
|
|
